The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis

References

• Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388–1398.
   PubMed Web of Science ®Google Scholar
• Kodama M, Matsumoto Y, Fujiwara M, Zhang SS, Hanawa H, Itoh E, Tsuda T, Izumi T, Shibata A. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 1991;69:1042–1050.
   Google Scholar
• Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994;75:278–284.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Kodama M, Aizawa Y. Immune-mediated myocarditis and inter leukin-10. Giora Z, Feuerstein PL, Mann DL. Inflammation and Cardiac Diseases. Basel: Birkhäusre Verlag; 2003. 189–202.
   Google Scholar
• Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Antioxid Redox Signal 2008;60:21–28.
   Google Scholar
• Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000;7:153–163.
   PubMedGoogle Scholar
• Younce CW, Kolattukudy PE. MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel Zn-finger protein, MCPIP. Biochem J 2010;43:43–53.
   Google Scholar
• Santos CX, Tanaka LY, Wosniak J, Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: role of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 2009;11:2409–2427.
   PubMed Web of Science ®Google Scholar
• Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381–389.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tanaka M, Watanabe K, Takamatsu Y, Tobe A. Research and development of the free radical scavenger edaravone as a neuroprotectant. Yakugaku Zasshi 2004;124: 99–111.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Jitsuiki D, Chayama K, Yoshizumi M. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2006;1:85–93.
   PubMedGoogle Scholar
• Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 1989;20:1236–1240.
   PubMed Web of Science ®Google Scholar
• Oishi R, Itoh Y, Nishibori M, Watanabe T, Nishi H, Saeki K. Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain. Stroke 1989;20:1557–1564.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994;268:1597–1604.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Egawa M. Effect of an antistoroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 1994;271:1624–1629.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Uzura M, Uchida K, Nakayama H, Furuya Y, Hayashi T, Sekino H, Ominato M, Owada S. Effects of edaravone on experimental brain injury in view of free radical reaction. Acta Neurochir Suppl 2003;86:309–311.
   PubMedGoogle Scholar
• Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T, Hida S, Nakamura Y, Nagayoshi Y, Sakamoto T, Yoshimura M, Arai H, Ogawa H. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004;94:481–484.
   PubMed Web of Science ®Google Scholar
• Fukudome D, Matsuda M, Kawasaki T, Ago Y, Matsuda T. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Eur J pharmacol 2008;583:164–169.
   PubMedGoogle Scholar
• Ikegami E, Fukazawa R, Kanbe M, Watanabe M, Abe M, Watanabe M, Kamisago M, Hajikano M, Katsube Y, Ogawa S. Edaravone, a potent free radical scavenger, prevents anthracycline-induced myocardial cell death. Circ J 2007;71: 1815–1820.
   PubMed Web of Science ®Google Scholar
• Qi X, Okuma Y, Hosoi T, Nomura Y. Edaravone protects against hypoxia/ischemia-induced endoplasmic reticulum dysfunction. J Pharmacol Exp Ther 2004;311:388–393.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Ohta Y, Nakazawa M, Higuchi H, Hasegawa G, Naito M, Fuse K, Ito M, Hirono S, Tanabe N, Hanawa H, Kato K, Kodama M, Aizawa Y. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 2000;130:1489–1495.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Watanabe K, Harima M, Thanikachalam PV, Yamaguchi K, Tachikawa H, Kodama M, Aizawa Y. Effects of various diuretics on cardiac function in rats with heart failure. Yakugaku Zasshi 2009;129:871–879.
   Google Scholar
• Tsutsui H, Kinugawa S, Matsushita S. Oxidative stress and mitochondrial DNA damage. Circ J 2008;72(suppl A): 31–37.
   Google Scholar
• Dhalla NS, Temsah RM, Netti Cadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655–673.
   PubMed Web of Science ®Google Scholar
• Tsujimoto I, Hikoso S, Yamaguchi O, Kashiwase K, Nakai A, Takeda T, Watanabe T, Taniike M, Matsumura Y, Nishida K, Hori M, Kogo M, Otsu K. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005;45:921–926.
   PubMed Web of Science ®Google Scholar
• Hewitson TD, Darby IA. In situ localization of apoptosis using TUNEL. Methods Mol Biol 2010;611:161–170.
   Google Scholar
• Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M, Shimazaki K, Katayama Y. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 2005;516:125–130.
   PubMed Web of Science ®Google Scholar
• Nimata M, Okabe T, Hattori M, Yuan Z, Shioji K, Kishimoto C. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Am J Physiol Heart Circ Physiol 2005;289:2514–2518.
   Google Scholar
• Okabe T, Kishimoto C, Hattori M, Nimata M, Shioji K, Kita T. Cardioprotective effects of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel free radical scavenger, on acute autoimmune myocarditis is rats. Exp Clin Cardiol 2004; 9:177–180.
   Google Scholar
• Yuan Z, Shioji Y, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 2004;286:83–90.
   PubMed Web of Science ®Google Scholar
• Einaga H, Yoshihara E, Matsuo Y, Yodoi J. Oxidative stress and redox regulation –protein oxidative modification and activation. Seibutsu Shiryo Bunseki 2009;32:265–272.
   Google Scholar
• Haliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57: 715–725.
   Google Scholar
• Ming W, Li S, Billadeau DD, Quilliam LA, Dinauer MC. The rac effector p67phox regulates phagocyte NADPH oxidase by stimulating vav1 guanine nucleotide exchange activity. Mol Cell Biol 2007;27:312–323.
   PubMed Web of Science ®Google Scholar
• Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, Tamaki T. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinase. Acta Pharmacol Sin 2004;25:977–985.
   PubMed Web of Science ®Google Scholar
• Minamino T, Kitakaze M. ER stress in cardiovascular disease. J Mol Cell 2010;48:1105–1110.
   Google Scholar
• Liu H, Li W, Gu W, Kong Y, Yang N, Chen L. Immunoregulatory effects of carvedilol on rats experimental autoimmune myocarditis. Scand J Immunol 2010;71:38–44.
   PubMed Web of Science ®Google Scholar
• Yang T, Mao YF, Liu SQ, Hou J, Cai ZY, Ni X, Deng XM, Zhu XY. Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury. Eur J Pharmacol 2010;630:152–157.
   PubMed Web of Science ®Google Scholar
• Prins D, Michalak M. Endoplasmic reticulum proteins in cardiac development and dysfunction. Can J Physiol Pharmacol 2009;87:419–425.
   Google Scholar
• Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 2007;22: 193–201.
   PubMed Web of Science ®Google Scholar
• Ueda S, Matsutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redoxcontrol of cell death. Antioxid Redox Signal 2002; 4:405–414.
   PubMed Web of Science ®Google Scholar
• Okada K, Minamino T, Kitakaze M. Role of endoplasmic reticulum stress in cardiac development and dysfunction. Folia Pharmacolo Jpn 2005;126:385–389.
   Google Scholar
• Haga T, Suzuki J, Kosuge H, Ogawa M, Saiki H, Haraguchi G, Maejima Y, Isobe M, Ueda T. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. J Mol Cell Cardiol 2009;46: 719–727.
   PubMedGoogle Scholar
• Wen J, Watanabe K, Ma M, Yamaguchi K, Tachikawa H, Kodama M, Aizawa Y. Edaravone inhibits JNK-c-Jun pathway and restores anti-oxidative defense after ischemia-reperfusion injury in aged rats. Biol Pharm Bull 2006;29:713–718.
   PubMed Web of Science ®Google Scholar